Indeed, oncogenic KRAS, closely related to lung adenocarcinoma development, induces an upregulation of the carrier SLC7A11 and, therefore, an increase in the intracellular concentration of cystine and cytoprotective glutathione in conditions of oxidative stress [168,169]. The gene discussed is KRAS; the disease is lung adenocarcinoma.